The Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with a large footprint in manufacturing and training in India, today hosted a high–level meeting with international delegates, government stakeholders, and MedTech industry captains at Shangri-La, New Delhi. The event was
A high-level government committee was constituted back in September 2021 to draft the New Drugs, Cosmetics and Medical Devices Bill which will be used for governance in the healthcare sector. The bill will be prepared under the chairmanship of the Drugs Controller General of India
In September 2021, the government constituted a high level committee for preparing of New Drugs, Cosmetics and Medical Devices Bill under the chairmanship of the Drugs Controller General of India. The committee recently consulted with consumer associations for their suggestions. As per the order issued by the
Pharmaceutical pricing regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the trade margin (actually mark up) for oxygen concentrators at 70 per cent. In its order dated 3rd June, 2021, the NPPA stated that the trade margin rationalization approach has been taken keeping in mind the
